Here are the DEF 14A proxy statements from P3 Health Partners Inc. Warrant (PIIIW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PIIIW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PIIIW filings page.
P3 Health Partners Inc. is calling a fully virtual 2026 annual stockholder meeting on June 9, 2026. Holders of Class A and Class V common stock as of April 10, 2026, totaling 3,318,290 Class A shares and 3,919,124 Class V shares, may vote.
Stockholders will elect three Class II directors, ratify BDO USA, P.C. as auditor, cast an advisory say‑on‑pay vote, and decide whether to approve the potential issuance of up to 3,341,130 Class A shares upon exercise of warrants held by VBC Growth SPV 5, LLC.
The warrants were issued alongside a Promissory Note providing up to $70 million of funding to subsidiary P3 Health Group, LLC, bearing 19.5% annual interest and various upfront and back-end fees. The proxy also details board structure, committee work, executive pay, and 2025 audit fees of $2,003,400.